Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

NCT07217587 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: Nipocalimab
DRUG: Efgartigimod

Sponsor

Janssen Research & Development, LLC